Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma.
Saved in:
| Title: | Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma. |
|---|---|
| Authors: | Ghansah T; Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Vohra N, Kinney K, Weber A, Kodumudi K, Springett G, Sarnaik AA, Pilon-Thomas S |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2013 Jun; Vol. 62 (6), pp. 1083-91. Date of Electronic Publication: 2013 Apr 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
